Deferasirox
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
0480-7011 -
Package NDC
0480-7011-56 -
Application number
ANDA207124 -
SPL ID
c6658799-331b-4e3e-9fa6-e8642cf4c9d6 -
SPL set ID
e9054806-2721-4736-9aef-81ffb8db75d1 -
UNII
V8G4MOF2V9 -
RxCUI
597768 -
RxCUI
597770 -
RxCUI
597772
What the source publishes
- Labeler
- Teva Pharmaceuticals, Inc.
- Active ingredients
- Deferasirox
- Form
- TABLET, FOR SUSPENSION
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Deferasirox",
"splId": "c6658799-331b-4e3e-9fa6-e8642cf4c9d6",
"labels": [
{
"setId": "e9054806-2721-4736-9aef-81ffb8db75d1",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e9054806-2721-4736-9aef-81ffb8db75d1",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e9054806-2721-4736-9aef-81ffb8db75d1"
}
],
"routes": [
"ORAL"
],
"labeler": "Teva Pharmaceuticals, Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "30 TABLET, FOR SUSPENSION in 1 BOTTLE (0480-7011-56)",
"package_ndc": "0480-7011-56",
"identifierStatus": "well-formed",
"marketing_start_date": "20241101"
}
],
"productId": "0480-7011_c6658799-331b-4e3e-9fa6-e8642cf4c9d6",
"useDomain": "unknown",
"dosageForm": "TABLET, FOR SUSPENSION",
"productNdc": "0480-7011",
"deaSchedule": null,
"genericName": "Deferasirox",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "DEFERASIROX",
"strength": "125 mg/1"
}
],
"applicationNumber": "ANDA207124",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20241101",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000000144",
"N0000175522",
"N0000185506",
"N0000187062",
"N0000182138"
],
"unii": [
"V8G4MOF2V9"
],
"rxcui": [
"597768",
"597770",
"597772"
],
"spl_set_id": [
"e9054806-2721-4736-9aef-81ffb8db75d1"
],
"pharm_class_epc": [
"Iron Chelator [EPC]"
],
"pharm_class_moa": [
"Iron Chelating Activity [MoA]",
"Cytochrome P450 3A4 Inducers [MoA]",
"Cytochrome P450 2C8 Inhibitors [MoA]",
"Cytochrome P450 1A2 Inhibitors [MoA]"
],
"manufacturer_name": [
"Teva Pharmaceuticals, Inc."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:0480-7011_c6658799-331b-4e3e-9fa6-e8642cf4c9d6"